ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,553,048, issued on Feb. 17, was assigned to NANJING UNIVERSITY (Nanjing, China).
"Multi-targeted siRNA for treating cancers" was invented by Chenyu Zhang (Nanjing, China), Xi Chen (Nanjing, China), Zheng Fu (Nanjing, China), Jing Li (Nanjing, China), Xiang Zhang (Nanjing, China) and Hongwei Liang (Nanjing, China).
According to the abstract* released by the U.S. Patent & Trademark Office: "A multi-targeted siRNA for treating cancers is disclosed. Specifically, an siRNA composition is provided, comprising: a first siRNA molecule that reduces the expression of the first target gene; optionally, a coding sequence targeting a peptide element; and optionally, a second siRNA molecule that r...